Benjamin T. Dake, SEE REMARKS at Aerovate Therapeutics, Inc. (AVTE), sold 19,466 shares at $22.56 ($443K) on 2022-12-08, disclosed to the SEC on 2022-12-12.
Open-market sale of $443k AVTE by SEE REMARKS. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.94 | 928 | $19K | 4.4% |
| 2 | $21.63 | 2,695 | $58K | 13.2% |
| 3 | $21.63 | 2,695 | $58K | 13.2% |
| 4 | $22.56 | 3,199 | $72K | 16.3% |
| 5 | $22.56 | 3,199 | $72K | 16.3% |
| 6 | $24.08 | 3,178 |
| $77K |
| 17.3% |
| 7 | $24.08 | 3,178 | $77K | 17.3% |
| 8 | $25.03 | 394 | $10K | 2.2% |
| Total | $22.77 avg | 19,466 | $443K | 100% |
| Filing → |
| AVTE | SELL | 2024-03-28 | $619K | — | Filing → |
| AVTE | SELL | 2024-03-27 | $192K | — | Filing → |
| AVTE | SELL | 2024-03-20 | $1.8M | — | Filing → |